Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000895421-25-000531·ESSA Pharma Inc.
Schedule 13G ownership disclosure
ESSA PHARMA INC
Common Shares · CUSIP: 29668H708
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Morgan Stanley
Shares: 1,904,062 · Class: 4.0%
- Morgan Stanley & Co. LLC
Shares: 0 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000895421-25-000531
- Form type
- SCHEDULE 13G/A
- Filer
- ESSA Pharma Inc.
- CIK
- CIK 1633932
- Filed
- Oct 07, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership